Skip to content

Eton Pharmaceuticals, Inc. ETON Other Non-Current Assets

Other Non-Current Assets at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$143K-51.2%
XER
Xeris Biopharma Holdings, Inc.XERS
$5.12M+0.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$61M-2.2%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$11.58M+12.2%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$8.48M-54.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s other non-current assets?
Eton Pharmaceuticals, Inc. (ETON) reported other non-current assets of $54K in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
Eton Pharmaceuticals, Inc.'s other non-current assets increased by 350.0% year-over-year, from $12K to $54K.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s other non-current assets has grown at a -13.8% compound annual growth rate (CAGR), from $40K to $19K.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.